Scynexis Inc
SCYX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178253
No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Scynexis Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Scynexis Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Burke Steven Keith | Director | 5,750 | Sep 22, 2026 | 1 |
| Subramanian Sanjay | Chief Financial Officer | – | Sep 11, 2026 | 1 |
| Anido Armando | Director | 11,750 | Jun 30, 2026 | 1 |
| Hastings David C | Director | 11,522 | Jun 30, 2026 | 1 |
| Hanham Ann | Director | 11,577 | Jun 30, 2026 | 1 |
| Macdonald Guy | Director | 12,625 | Jun 30, 2026 | 1 |
| Tinmouth Brian Philippe | Director | 12,125 | Jun 30, 2026 | 1 |
| Angulo Gonzalez David | Chief Executive Officer | 1,357,126 | Apr 2, 2026 | 3 |
| Sukenick Scott | Chief Legal Officer | 574,539 | Feb 2, 2026 | 1 |
| Macleod ivor | Chief Financial Officer | 398,529 | Feb 2, 2026 | 1 |
| Gilman Steven C | Director | 70,000 | Jun 30, 2025 | 0 |
| Taglietti Marco | Chief Executive Officer | 272,068 | Apr 28, 2022 | 0 |
| Coyne Christine | Chief Commercial Officer | 58,200 | Feb 8, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Angulo Gonzalez DavidChief Executive Officer | PPurchase | +108.7K | – | – | +8.7%1.36M after | |
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Angulo Gonzalez DavidChief Executive Officer | PPurchase | +108.7K | – | – | –108.7K after | Derivative |
| Sep 16, 2024 (view filing) | Sep 12 | 4 days | Angulo Gonzalez DavidChief Executive Officer | PPurchase | +20.0K | $1.37 | +$27.4K | +4.1%507.9K after | |
| Apr 28, 2022 (view filing) | Apr 26 | 2 days | Taglietti MarcoChief Executive Officer | PPurchase | +75.0K | $3.00 | +$225.0K | +38.1%272.1K after | |
| Apr 28, 2022 (view filing) | Apr 26 | 2 days | Sukenick ScottGeneral Counsel | PPurchase | +3.50K | $3.00 | +$10.5K | +7.0%53.5K after |